Annual Net Income:
-$569.18M+$37.46M(+6.17%)Summary
- As of today, RARE annual net profit is -$569.18 million, with the most recent change of +$37.46 million (+6.17%) on December 31, 2024.
- During the last 3 years, RARE annual net income has fallen by -$115.16 million (-25.36%).
- RARE annual net income is now -7523.67% below its all-time high of -$7.47 million, reached on December 31, 2011.
Performance
RARE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$114.95M+$36.13M(+23.91%)Summary
- As of today, RARE quarterly net profit is -$114.95 million, with the most recent change of +$36.13 million (+23.91%) on June 30, 2025.
- Over the past year, RARE quarterly net income has increased by +$16.65 million (+12.65%).
- RARE quarterly net income is now -479.97% below its all-time high of $30.25 million, reached on March 31, 2018.
Performance
RARE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$532.93M+$16.65M(+3.03%)Summary
- As of today, RARE TTM net profit is -$532.93 million, with the most recent change of +$16.65 million (+3.03%) on June 30, 2025.
- Over the past year, RARE TTM net income has increased by +$52.19 million (+8.92%).
Performance
RARE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RARE Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +6.2% | +12.7% | +8.9% |
| 3Y3 Years | -25.4% | +27.3% | -5.3% |
| 5Y5 Years | -41.3% | -554.1% | -107.9% |
RARE Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -25.4% | +19.5% | at high | +53.1% | at high | +26.1% |
| 5Y | 5-Year | -205.1% | +19.5% | -378.7% | +53.1% | -185.7% | +26.1% |
| All-Time | All-Time | -7523.7% | +19.5% | -480.0% | +53.1% | >-9999.0% | +26.1% |
RARE Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$114.95M(+23.9%) | -$532.93M(+3.0%) |
| Mar 2025 | - | -$151.08M(-13.3%) | -$549.58M(+3.4%) |
| Dec 2024 | -$569.18M(+6.2%) | -$133.38M(+0.1%) | -$569.18M(-1.8%) |
| Sep 2024 | - | -$133.52M(-1.5%) | -$558.99M(+4.5%) |
| Jun 2024 | - | -$131.60M(+22.9%) | -$585.12M(+4.6%) |
| Mar 2024 | - | -$170.68M(-38.6%) | -$613.35M(-1.1%) |
| Dec 2023 | -$606.64M(+14.2%) | -$123.19M(+22.8%) | -$606.64M(+4.5%) |
| Sep 2023 | - | -$159.65M(+0.1%) | -$635.28M(+11.9%) |
| Jun 2023 | - | -$159.83M(+2.5%) | -$720.74M(-0.2%) |
| Mar 2023 | - | -$163.97M(-8.0%) | -$719.07M(-1.6%) |
| Dec 2022 | -$707.42M(-55.8%) | -$151.83M(+38.1%) | -$707.42M(-4.3%) |
| Sep 2022 | - | -$245.11M(-55.0%) | -$678.05M(-34.0%) |
| Jun 2022 | - | -$158.16M(-3.8%) | -$505.94M(-7.6%) |
| Mar 2022 | - | -$152.32M(-24.4%) | -$470.20M(-3.6%) |
| Dec 2021 | -$454.02M(-143.4%) | -$122.46M(-67.8%) | -$454.02M(-27.7%) |
| Sep 2021 | - | -$73.00M(+40.4%) | -$355.58M(-1.2%) |
| Jun 2021 | - | -$122.43M(+10.1%) | -$351.43M(-72.5%) |
| Mar 2021 | - | -$136.14M(-467.0%) | -$203.68M(-9.2%) |
| Dec 2020 | -$186.57M(+53.7%) | -$24.01M(+65.1%) | -$186.57M(+27.2%) |
| Sep 2020 | - | -$68.84M(-372.0%) | -$256.36M(+14.7%) |
| Jun 2020 | - | $25.32M(+121.3%) | -$300.51M(+29.3%) |
| Mar 2020 | - | -$119.03M(-26.9%) | -$425.00M(-5.5%) |
| Dec 2019 | -$402.73M(-103.8%) | -$93.81M(+17.0%) | -$402.73M(-1.5%) |
| Sep 2019 | - | -$112.99M(-13.9%) | -$396.75M(-6.9%) |
| Jun 2019 | - | -$99.17M(-2.5%) | -$371.06M(-14.3%) |
| Mar 2019 | - | -$96.76M(-10.2%) | -$324.62M(-64.3%) |
| Dec 2018 | -$197.61M | -$87.83M(-0.6%) | -$197.61M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$87.31M(-65.6%) | -$191.52M(-4.4%) |
| Jun 2018 | - | -$52.73M(-274.3%) | -$183.43M(+9.9%) |
| Mar 2018 | - | $30.25M(+137.0%) | -$203.60M(+32.6%) |
| Dec 2017 | -$302.14M(-22.9%) | -$81.73M(-3.2%) | -$302.14M(-3.6%) |
| Sep 2017 | - | -$79.23M(-8.7%) | -$291.69M(-5.2%) |
| Jun 2017 | - | -$72.89M(-6.7%) | -$277.38M(-6.1%) |
| Mar 2017 | - | -$68.29M(+4.2%) | -$261.41M(-6.3%) |
| Dec 2016 | -$245.87M(-68.8%) | -$71.29M(-9.8%) | -$245.87M(-7.0%) |
| Sep 2016 | - | -$64.91M(-14.0%) | -$229.81M(-12.6%) |
| Jun 2016 | - | -$56.92M(-7.9%) | -$204.13M(-15.3%) |
| Mar 2016 | - | -$52.76M(+4.5%) | -$177.00M(-21.5%) |
| Dec 2015 | -$145.62M(-143.5%) | -$55.22M(-40.8%) | -$145.62M(-35.9%) |
| Sep 2015 | - | -$39.23M(-31.7%) | -$107.14M(-27.9%) |
| Jun 2015 | - | -$29.79M(-39.3%) | -$83.75M(-24.0%) |
| Mar 2015 | - | -$21.38M(-27.7%) | -$67.55M(-13.0%) |
| Dec 2014 | -$59.80M(-70.5%) | -$16.74M(-5.6%) | -$59.80M(-10.0%) |
| Sep 2014 | - | -$15.85M(-16.7%) | -$54.38M(-6.4%) |
| Jun 2014 | - | -$13.59M(+0.3%) | -$51.12M(-36.2%) |
| Mar 2014 | - | -$13.63M(-20.4%) | -$37.54M(-22.5%) |
| Dec 2013 | -$35.07M(-79.3%) | -$11.32M(+10.1%) | -$30.64M(-17.2%) |
| Sep 2013 | - | -$12.59M(>-9900.0%) | -$26.14M(-38.7%) |
| Jun 2013 | - | $0.00(+100.0%) | -$18.85M(0.0%) |
| Mar 2013 | - | -$6.74M(+1.1%) | -$18.85M(-55.6%) |
| Dec 2012 | -$19.56M(-162.0%) | -$6.81M(-28.5%) | -$12.11M(-128.5%) |
| Sep 2012 | - | -$5.30M(>-9900.0%) | -$5.30M(>-9900.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00 | $0.00 |
| Dec 2011 | -$7.47M | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual net profit?
- What is the all-time high annual net income for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual net income year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly net profit?
- What is the all-time high quarterly net income for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly net income year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM net profit?
- What is the all-time high TTM net income for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM net income year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual net profit?
The current annual net income of RARE is -$569.18M
What is the all-time high annual net income for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual net profit is -$7.47M
What is Ultragenyx Pharmaceutical Inc. annual net income year-on-year change?
Over the past year, RARE annual net profit has changed by +$37.46M (+6.17%)
What is Ultragenyx Pharmaceutical Inc. quarterly net profit?
The current quarterly net income of RARE is -$114.95M
What is the all-time high quarterly net income for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly net profit is $30.25M
What is Ultragenyx Pharmaceutical Inc. quarterly net income year-on-year change?
Over the past year, RARE quarterly net profit has changed by +$16.65M (+12.65%)
What is Ultragenyx Pharmaceutical Inc. TTM net profit?
The current TTM net income of RARE is -$532.93M
What is the all-time high TTM net income for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM net profit is $0.00
What is Ultragenyx Pharmaceutical Inc. TTM net income year-on-year change?
Over the past year, RARE TTM net profit has changed by +$52.19M (+8.92%)